Injection of LRP5 and LRP6 antibodies suppressed activation of the Wnt pathway and decreased the formation of extracellular matrix in DN animal models, suggesting that Wnt/β-catenin signaling might be involved in tubular-interstitial fibrosis in DN. Here, LRP6 is linked to liver dysplastic nodule.